The treatment for acquired reactive perforating collagenosis with abrocitinib: A case report.
作者信息
Liu Boqiang, Fu Mengchen, Zheng Kaifu, Gao Meng, Zou Xiangling, He Na, Yu Shuzhen, Zhang Xiaoning, Li Chengxin
机构信息
Department of Dermatology, The 991st Hospital of Joint Logistic Support Force of PLA, Xiangyang, China.
Department of General Surgery, The 991st Hospital of Joint Logistic Support Force of PLA, Xiangyang, China.
出版信息
JAAD Case Rep. 2025 Jul 23;64:119-121. doi: 10.1016/j.jdcr.2025.07.005. eCollection 2025 Oct.
Abstract
摘要
相似文献
1
The treatment for acquired reactive perforating collagenosis with abrocitinib: A case report.用阿布昔替尼治疗获得性反应性穿通性胶原病：一例报告。
JAAD Case Rep. 2025 Jul 23;64:119-121. doi: 10.1016/j.jdcr.2025.07.005. eCollection 2025 Oct.
2
Successful Nemolizumab Treatment of Refractory Acquired Reactive Perforating Collagenosis in a Diabetic Patient.奈莫利珠单抗成功治疗一名糖尿病患者的难治性获得性反应性穿通性胶原病
Cureus. 2025 Jul 28;17(7):e88884. doi: 10.7759/cureus.88884. eCollection 2025 Jul.
3
Acquired Reactive Perforating Collagenosis: A Case Report.获得性反应性穿孔性胶原病：一例报告
Cureus. 2021 Feb 27;13(2):e13583. doi: 10.7759/cureus.13583.
4
Acquired reactive perforating collagenosis in association with prostate adenocarcinoma, chronic lymphocytic leukemia, and Graves' disease.获得性反应性穿通性胶原病伴前列腺腺癌、慢性淋巴细胞白血病及格雷夫斯病。
An Bras Dermatol. 2020 May-Jun;95(3):336-339. doi: 10.1016/j.abd.2019.09.029. Epub 2020 Apr 18.
5
Acquired reactive perforating collagenosis secondary to Cabozantinib: A case report and literature review.卡博替尼继发的获得性反应性穿通性胶原病：一例报告及文献复习
SAGE Open Med Case Rep. 2024 Dec 16;12:2050313X241304961. doi: 10.1177/2050313X241304961. eCollection 2024.
6
Giant acquired reactive perforating collagenosis in a patient with diabetes mellitus and metastatic breast carcinoma.一名患有糖尿病和转移性乳腺癌的患者出现巨大获得性反应性穿通性胶原病。
JAAD Case Rep. 2016 Jan 14;2(1):22-4. doi: 10.1016/j.jdcr.2015.11.013. eCollection 2016 Jan.
7
Allopurinol in the treatment of acquired reactive perforating collagenosis.别嘌醇治疗获得性反应性穿通性胶原病。
An Bras Dermatol. 2013 Jan-Feb;88(1):94-7. doi: 10.1590/s0365-05962013000100012.
8
Acquired reactive perforating collagenosis in a nondiabetic hemodialysis patient: successful treatment with allopurinol.一名非糖尿病血液透析患者的获得性反应性穿通性胶原病：别嘌醇治疗成功
Am J Kidney Dis. 2003 Sep;42(3):E11-3. doi: 10.1016/s0272-6386(03)00796-0.
9
Acquired reactive perforating collagenosis: A case report and review of the literature.获得性反应性穿通性胶原病：一例报告及文献复习
Medicine (Baltimore). 2020 May 29;99(22):e20391. doi: 10.1097/MD.0000000000020391.
10
Acquired reactive perforating collagenosis: current status.获得性反应性穿孔性胶原病：现状。
J Dermatol. 2010 Jul;37(7):585-92. doi: 10.1111/j.1346-8138.2010.00918.x.
本文引用的文献
1
Unraveling the Enigma of Perforating Itches: A Comprehensive Report of Reactive Perforating Collagenosis in Three Patients.揭开穿孔性瘙痒之谜：三例反应性穿孔性胶原病的综合报告
Cureus. 2023 Sep 1;15(9):e44531. doi: 10.7759/cureus.44531. eCollection 2023 Sep.
2
Successful management of a severe case of chronic giant acquired reactive perforating collagenosis with allopurinol.用别嘌醇成功治疗一例严重慢性巨块型获得性反应性穿通性胶原病
JAAD Case Rep. 2023 Aug 14;40:99-102. doi: 10.1016/j.jdcr.2023.07.040. eCollection 2023 Oct.
3
Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation.度普利尤单抗可改善由 2 型炎症引起的获得性反应性穿孔性胶原病。
Front Immunol. 2023 Aug 10;14:1240262. doi: 10.3389/fimmu.2023.1240262. eCollection 2023.
4
μ-opioid receptor overexpression in acquired reactive perforating collagenosis associated with IL-31.
J Dermatol Sci. 2023 May;110(2):69-71. doi: 10.1016/j.jdermsci.2023.04.003. Epub 2023 Apr 14.
5
Coexistent Lichen Amyloidosis and Acquired Reactive Perforating Collagenosis in Type 2 Diabetes Mellitus and Post-Thyroidectomy Hypothyroidism Due to Papillary Thyroid Carcinoma: A Rare Case.2型糖尿病合并甲状腺乳头状癌所致甲状腺切除术后甲状腺功能减退症患者同时存在苔藓样淀粉样变和获得性反应性穿通性胶原病：1例罕见病例。
Int Med Case Rep J. 2022 Dec 20;15:745-752. doi: 10.2147/IMCRJ.S391199. eCollection 2022.
6
Reactive perforating collagenosis successfully treated with dupilumab.度普利尤单抗成功治疗反应性穿通性胶原病。
Australas J Dermatol. 2022 Aug;63(3):398-400. doi: 10.1111/ajd.13874. Epub 2022 May 28.
7
Successful treatment of acquired reactive perforating collagenosis with itraconazole.伊曲康唑成功治疗获得性反应性穿孔性胶原病。
Eur J Med Res. 2021 Jul 13;26(1):74. doi: 10.1186/s40001-021-00542-6.
8
JAK-inhibitors in dermatology: current evidence and future applications.皮肤科中的 JAK 抑制剂：现有证据和未来应用。
J Dermatolog Treat. 2019 Nov;30(7):648-658. doi: 10.1080/09546634.2018.1546043. Epub 2018 Dec 3.
9
Acquired reactive perforating collagenosis. Report of six cases and review of the literature.获得性反应性穿通性胶原病。6例报告及文献复习。
J Am Acad Dermatol. 1994 Apr;30(4):575-80. doi: 10.1016/s0190-9622(94)70065-6.
Zotero 插件